Eric Sugalski is an accomplished professional in the medical device industry, serving as the Founder and CTO of Archimedic since February 2009, where expertise spans design, development, regulatory affairs, and commercial strategy. As the Founder and CEO, Archimedic has significantly impacted areas such as cancer care, hip fracture prevention, and drug cost reduction. Additionally, Eric operates as a MedTech Investor for Robin Hood Ventures, supporting early-stage companies in the Greater Philadelphia region, and holds an adjunct assistant professor position at West Chester University, teaching Regulatory & GMP in a new Biomedical Engineering Program. Past educational roles include lecturing in Bioengineering at the University of Pennsylvania and Mechanical Engineering at MIT. Eric's academic background includes an MBA from the Massachusetts Institute of Technology and a BSME from the University of Colorado Boulder.